USE OF ADEFVE OR TENOFOVIR TO INHIBIT VTMR TYPE VIRUSES INVOLVED IN BREAST CANCER AND IN PRIMARY BILIAR CIRRHOSIS.

摘要

The use of adefovir or tenofovir to prepare a pharmaceutical formulation to treat breast cancer in mammals, in which VTMR retroviruses are the etiologic agents, or human primary biliary cirrhosis, in which VTMR retroviruses are the etiological agents, inhibiting the activity of the reverse transcriptase of retrovirus type VTMR.